Skip to main content Accessibility help
×
Home

Pharmacotherapy for borderline personality disorder: NICE guideline

  • Tim Kendall (a1), Rachel Burbeck (a2) and Anthony Bateman (a3)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pharmacotherapy for borderline personality disorder: NICE guideline
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Pharmacotherapy for borderline personality disorder: NICE guideline
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Pharmacotherapy for borderline personality disorder: NICE guideline
      Available formats
      ×

Copyright

References

Hide All
1 Lieb, K, Völlm, B, Rücker, G, Timmer, A, Stoffers, JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010; 196: 412.
2 National Collaborating Centre for Mental Health. Borderline Personality Disorder: The NICE GUIDELINE on Treatment and Management. National Clinical Practice Guideline No. 78. British Psychological Society & Royal College of Psychiatrists, 2009.
3 Nickel, MK, Nickel, C, Mitterlehner, FO, Tritt, K, Lahmann, C, Lieberich, PK, et al. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 2004; 65: 1515–9.
4 Nickel, MK, Nickel, C, Kaplan, P, Lahmann, C, Muhlbacher, M, Tritt, K, et al. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 2005; 57: 495–9.
5 Tritt, K, Nickel, C, Lahmann, C, Lieberich, PK, Rother, WK, Loew, TH, et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo controlled study. J Psychopharmacol 2005; 19: 287–91.
6 Loew, TH, Nickel, MK, Muehlbacher, M, Kaplan, P, Nickel, C, Kettler, C, et al. Topiramate treatment for women with borderline personality disorder. A double-blind, placebo controlled study. J Clin Psychopharmacol 2006; 26: 61–6.
7 Nickel, MK, Muehlbacher, M, Nickel, C, Kettler, C, Pedrosa, G, Bachler, E, et al. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo controlled study. Am J Psychiatry 2006; 163: 833–8.
8 Montgomery, SA, Roy, D, Montgomery, DB. The prevention of recurrent suicidal acts. Br J Clin Pharmacol 1983; 15 (suppl 2): 183S8S.
9 American Psychiatric Association. Practice guidelines for the treatment of borderline personality disorder. Am J Psych 2001; 158 (suppl 10): 152.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Pharmacotherapy for borderline personality disorder: NICE guideline

  • Tim Kendall (a1), Rachel Burbeck (a2) and Anthony Bateman (a3)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *